Ella J. Ariza-Heredia, MD

Peer-Reviewed Articles

1. Ariza-Heredia EJ, Winston DJ, Rowley SD, Mullane K, Chandrasekar P, Hari P, Avery RK, Peggs KS, Kumar D, Nath R, Ljungman P, Mossad SB, El Haddad L, Shah DP, Jiang Y, Khawaja F, Dadwal S, Blanchard T, Chemaly RF. Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant. Open Forum Infect Dis 10(8):ofad386, 2023. e-Pub 2023. PMID: 37636519.
2. Spallone A, Ariza-Heredia EJ, Chemaly RF. Acute and Latent Viral Infections in Immunocompromised Patients: A Tale of Brave Battles and Menacing Foes. Clin Microbiol Infect 28(10):1319-1320, 2022. e-Pub 2022. PMID: 35724870.
3. Strati P, Varma A, Adkins S, Nastoupil LJ, Westin J, Hagemeister FB, Fowler NH, Lee HJ, Fayad LE, Samaniego F, Ahmed S, Chen Y, Horowitz S, Arafat S, Johncy S, Kebriaei P, Mulanovich VE, Ariza-Heredia EJ, Neelapu SS. Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma. Haematologica 106(10):2667-2672, 2021. e-Pub 2021. PMID: 32732355.
4. Ariza-Heredia EJ, Frenzel E, Cantu S, Carlson M, Thomas G, Khawaja F, Raad II, Chemaly RF. Surveillance and identification of clusters of health care workers with COVID-19: Multidimensional interventions at a comprehensive cancer center. Infect Control Hosp Epidemiol 42(7):1-21, 2021. e-Pub 2020. PMID: 33183368.
5. Figgins B, Hammerstrom A, Ariza-Heredia E, Oran B, Milton DR, Yeh J. Characterization of viral Infections after antithymocyte globulin-based conditioning in adults undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 25(9):1837-1843, 2019. e-Pub 2019. PMID: 31128324.
6. Doan VP, Yeh JC, Gulbis AM, Aitken SL, Ariza-Heredia E, Ahmed S. Levofloxacin versus cefpodoxime for antibacterial prophylaxis in allogeneic stem cell transplantation. Biol Blood Marrow Transplant 25(8):1637-1641, 2019. e-Pub 2019. PMID: 31002991.
7. El Haddad L, Ariza-Heredia E, Shah DP, Jiang Y, Blanchard T, Ghantoji SS, El Chaer F, El-Haddad D, Prayag A, Nesher L, Rezvani K, Shpall E, Chemaly RF. The ability of a cytomegalovirus ELISPOT assay to predict outcome of low-level CMV reactivation in hematopoietic stem cell transplant recipients. J Infect Dis 219(6):898-907, 2019. e-Pub 2018. PMID: 30295846.
8. Vakil E, Sheshadri A, Faiz SA, Shah DP, Zhu Y, Li L, Kmeid J, Azzi J, Balagani A, Bashoura L, Ariza-Heredia E, Chemaly RF. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies. Transpl Infect Dis 20(6):e12994, 2018. e-Pub 2018. PMID: 30195271.
9. Azzi JM, Kyvernitakis A, Shah DP, El Haddad L, Mahajan SN, Ghantoji SS, Ariza-Heredia E, Chemaly RF. Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection. J Antimicrob Chemother 73(11):3162-3169, 2018. PMID: 30113677.
10. Ariza-Heredia EJ, Chemaly RF. Update on infection control practices in cancer hospitals. CA Cancer J Clin 68(5):340-355, 2018. e-Pub 2018. PMID: 29985544.
11. Foolad F, Aitken SL, Shigle TL, Prayag A, Ghantoji S, Ariza-Heredia E, Chemaly RF. Oral versus aerosolized ribavirin for the treatment of respiratory syncytial virus infections in hematopoietic stem cell transplantation recipients. Clin Infect Dis. e-Pub 2018. PMID: 30202920.
12. Mah A, Viola GM, Ariza Heredia E, Rezvani K, Kebriaei P, Bhatti MM, Han X, Shpall EJ, Mulanovich VE. Graft loss attributed to possible transfusion-transmitted ehrlichiosis following cord blood stem cell transplant. Transpl Infect Dis 20(4):e12899, 2018. e-Pub 2018. PMID: 29668040.
13. Ariza-Heredia EJ, Chemaly RF, Shahani LR, Jang Y, Champlin RE, Mulanovich VE. Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study. Transpl Int 31(6):639-648, 2018. e-Pub 2018. PMID: 29464765.
14. Hwang JP, Ahmed S, Ariza-Heredia EJ, Duan Z, Zhao H, Schmeler KM, Ramondetta L, Parker SL, Suarez-Almazor ME, Ferrajoli A, Shih YT, Giordano SH, Chiao EY. Low rate of cervical cancer screening among women with hematologic malignancies after stem cell transplant. Biol Blood Marrow Transplant 24(5):1094-1098, 2018. e-Pub 2018. PMID: 29378304.
15. Ariza-Heredia EJ, Granwehr BP, Viola GM, Bhatti M, Kelley JM, Kochenderfer J, Hosing C. False-positive HIV nucleic acid amplification testing during CAR T-cell therapy. Diagn Microbiol Infect Dis 88(4):305-307, 2017. e-Pub 2017. PMID: 28610774.
16. El Chaer F, Shah DP, Kmeid J, Ariza-Heredia EJ, Hosing CM, Mulanovich VE, Chemaly RF. Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes. Cancer 123(12):2329-2337, 2017. e-Pub 2017. PMID: 28178369.
17. Shahani L, Ariza-Heredia EJ, Chemaly RF. Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev Anti Infect Ther 15(4):1-15, 2017. e-Pub 2017. PMID: 28067078.
18. Vergidis P, Ariza-Heredia EJ, Nellore A, Kotton CN, Kaul DR, Morris MI, Kelesidis T, Shah T, Park SY, Nguyen MH, Razonable RR.. Rhodococcus infection in solid organ and hematopoietic stem cell transplant recipients. Emerg Infect Dis 23(3):510-512. e-Pub 2017.
19. Oliver NT, Nieto YL, Blechacz B, Anderlini P, Ariza-Heredia E, Torres HA. Severe hepatitis C reactivation as an early complication of hematopoietic cell transplantation. Bone Marrow Transplant 52(1):138-140, 2017. e-Pub 2016. PMID: 27427916.
20. El Chaer F, Mori N, Shah D, Oliver N, Wang E, Jan A, Doan V, Tverdek F, Tayar J, Ariza-Heredia E, Chemaly RF. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series. Antiviral Res 135:91-96, 2016. e-Pub 2016. PMID: 27594527.
21. El-Haddad D, El Chaer F, Vanichanan J, Shah DP, Ariza-Heredia EJ, Mulanovich VE, Gulbis AM, Shpall EJ, Chemaly RF. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience. Antiviral Res 134:58-62, 2016. e-Pub 2016. PMID: 27582067.
22. Frenzel E, Chemaly RF, Ariza-Heredia E, Jiang Y, Shah DP, Thomas G, Graviss L, Raad I. Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients. Am J Infect Control 44(9):1016-21, 2016. e-Pub 2016. PMID: 27158088.
23. Gutierrez C, Kebriaei P, Turner KA, Yemelyanova A, Ariza-Heredia EJ, Foo WC. A unique presentation of acute liver failure from herpes simplex virus hepatitis. Transpl Infect Dis 18(4):592-4, 2016. e-Pub 2016. PMID: 27222930.
24. Mahale P, Sturgis EM, Tweardy DJ, Ariza-Heredia EJ, Torres HA. Association between hepatitis C virus and head and neck cancers. J Natl Cancer Inst 108(8), 2016. e-Pub 2016. PMID: 27075854.
25. Nesher L, Shah DP, Ariza-Heredia EJ, Azzi JM, Siddiqui HK, Ghantoji SS, Marsh LY, Michailidis L, Makedonas G, Rezvani K, Shpall EJ, Chemaly RF. Utility of the enzyme-linked immunospot interferon-γ-release assay to predict the risk of cytomegalovirus infection in hematopoietic cell transplant recipients. J Infect Dis 213(11):1701-7, 2016. e-Pub 2016. PMID: 26908740.
26. Kmeid J, Vanichanan J, Shah DP, El Chaer F, Azzi J, Ariza-Heredia EJ, Hosing C, Mulanovich V, Chemaly RF. Outcomes of influenza infections in hematopoietic cell transplant recipients: Application of an immunodeficiency scoring index. Biol Blood Marrow Transplant 22(3):542-8, 2016. e-Pub 2015. PMID: 26638804.
27. Ariza-Heredia EJ, Azzi J, Shah DP, Nesher L, Ghantoji SS, Michailidis L, Marsh L, Chemaly RF. Influenza vaccination in patients with cancer: Factors associated with vaccination practices for patients and their household members. Infect Control Hosp Epidemiol 36(10):1-3, 2015. e-Pub 2015. PMID: 26132392.
28. Nesher L, Rolston KV, Shah DP, Tarrand JT, Mulanovich V, Ariza-Heredia EJ, Chemaly RF. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 17(1):33-8, 2015. e-Pub 2014. PMID: 25546740.
29. Chemaly RF, Dantes R, Shah DP, Shah PK, Pascoe N, Ariza-Heredia E, Perego C, Nguyen DB, Nguyen K, Modarai F, Moulton-Meissner H, Noble-Wang J, Tarrand JJ, LiPuma JJ, Guh AY, MacCannell T, Raad I, Mulanovich V. Cluster and sporadic cases of herbaspirillum species infections in patients with cancer. Clin Infect Dis 60(1):48-54, 2015. e-Pub 2014. PMID: 25216687.
30. Ariza-Heredia EJ, Gulbis AM, Stolar KR, Kebriaei P, Shah DP, McConn KK, Champlin RE, Chemaly RF. Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice. Transpl Infect Dis 16(6):878-86, 2014. e-Pub 2014. PMID: 25405922.
31. Torres HA, Rallapalli V, Saxena A, Granwehr BP, Viola GM, Ariza-Heredia E, Adachi JA, Chemaly RF, Marfatia R, Jiang Y, Mahale P, Kyvernitakis A, Fanale MA, Mulanovich V. Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Clin Microbiol Infect 20(10):O672-9, 2014. e-Pub 2014. PMID: 24529214.
32. Ariza-Heredia EJ, Chemaly RF. Infection control practices in patients with hematological malignancies and multi-drug resistant organisms: special considerations and challenges. Clin Lymphoma Myeloma Leuk 14 Suppl:S104-10, 2014. PMID: 25486947.
33. Chemaly RF, Ghantoji SS, Shah DP, Shah JN, El Taoum KK, Champlin RE, Nunez CA, Mulanovich V, Ariza-Heredia E. Respiratory syncytial virus infections in children with cancer. J Pediatr Hematol Oncol 36(6):e376-81, 2014. e-Pub 2013. PMID: 24327130.
34. Ariza-Heredia EJ, Kontoyiannis DP. Our recommendations for avoiding exposure to fungi outside the hospital for patients with haematological cancers. Mycoses 57(6):336-41, 2014. e-Pub 2014. PMID: 24446760.
35. Ariza-Heredia EJ, Beam EN, Lesnick TG, Cosio FG, Kremers WK, Razonable RR. Impact of urinary tract infection on allograft function after kidney transplantation. Clin Transplant 28(6):683-90, 2014. e-Pub 2014. PMID: 24654771.
36. Shah DP, Ghantoji SS, Ariza-Heredia EJ, Shah JN, El Taoum KK, Shah PK, Nesher L, Hosing C, Rondon G, Champlin RE, Chemaly RF. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections. Blood 123(21):3263-8, 2014. e-Pub 2014. PMID: 24700783.
37. Mahajan SN, Ariza-Heredia EJ, Rolston KV, Graviss LS, Feig BW, Aloia TA, Chemaly RF. Perioperative antimicrobial prophylaxis for intra-abdominal surgery in patients with cancer: a retrospective study comparing ertapenem and non-ertapenem antibiotics. Ann Surg Oncol 21(2):513-9, 2014. e-Pub 2013. PMID: 24114052.
38. Ariza-Heredia EJ, Beam EN, Lesnick TG, Kremers WK, Cosio FG, Razonable RR. Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transplant 18:195-204, 2013. e-Pub 2013. PMID: 23792521.
39. Ariza-Heredia EJ, Patel R, Blumberg EA, Walker RC, Lewis R, Evans J, Sankar A, Willliams MD, Rogers J, Milano C, Razonable RR. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Transpl Infect Dis 14(3):229-36, 2012. e-Pub 2012. PMID: 22624726.
40. Ariza-Heredia E, Razonable RR. Incidental hepatic schistosomiasis in a liver transplant recipient. Transpl Infect Dis 14(1):75-8, 2012. e-Pub 2011. PMID: 21504529.
41. Ariza-Heredia EJ, Fishman JE, Cleary T, Smith L, Razonable RR, Abbo L. Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single-center experience. Transpl Infect Dis 14(1):64-71, 2012. e-Pub 2011. PMID: 22093238.
42. Shah DP, Ghantoji SS, Mulanovich VE, Ariza-Heredia EJ, Chemaly RF. Management of respiratory viral infections in hematopoietic cell transplant recipients. Am J Blood Res 2(4):203-18, 2012. e-Pub 2012. PMID: 23226621.
43. Ariza-Heredia EJ, Dababneh AS, Wilhelm MP, Wengenack NL, Razonable RR, Wilson JW. Mycobacterium wolinskyi: a case series and review of the literature. Diagn Microbiol Infect Dis 71(4):421-7, 2011. e-Pub 2011. PMID: 21945390.
44. Ariza-Heredia EJ, Razonable RR. Human herpes virus 8 in solid organ transplantation. Transplantation 92(8):837-44, 2011. PMID: 21946171.
45. Ariza Heredia E, Espinoza L, Abbo L. Salmonella bacteremia and ovarian abscess in an HIV-infected woman. Inf Dis in Clinical Practice 19(6):442-444, 2011.
46. Abbo L, Sinkowitz-Cochran R, Smith L, Ariza-Heredia E, Gómez-Marín O, Srinivasan A, Hooton TM. Faculty and resident physicians' attitudes, perceptions, and knowledge about antimicrobial use and resistance. Infect Control Hosp Epidemiol 32(7):714-8, 2011. PMID: 21666405.
47. Munoz-Price LS, Ariza-Heredia E, Adams S, Olivier M, Francois L, Socarras M, Coro G, Adedokun A, Pappas T, Tamayo M, McDade R, Dezfulian C. Use of UV powder for surveillance to improve environmental cleaning. Infect Control Hosp Epidemiol 32(3):283-5, 2011. PMID: 21460514.
48. Abbo L, Quartin A, Morris MI, Saigal G, Ariza-Heredia E, Mariani P, Rodriguez O, Muñoz-Price LS, Ferrada M, Ramee E, Rosas MI, Gonzalez IA, Fishman J. Pulmonary imaging of pandemic influenza H1N1 infection: relationship between clinical presentation and disease burden on chest radiography and CT. Br J Radiol 83(992):645-51, 2010. e-Pub 2010. PMID: 20551254.

Invited Articles

1. Ariza-Heredia EJ, Chemaly RF. Practical Review of Immunizations in Adult Patients with Cancer. Hum Vaccin Immunother 11(11):2606-14, 2015. e-Pub 2015. PMID: 26110220.
2. Abbo LM, Ariza-Heredia EJ. Antimicrobial Stewardship in Immunocompromised Hosts. Infect Dis Clin North Am 28(2):263-79, 2014. PMID: 24857392.
3. Ariza-Heredia EJ, Nesher L, Chemaly RF. Cytomegalovirus Diseases after Hematopoietic Stem Cell Transplantation: A Mini-Review. Cancer Lett 342(1):1-8, 2014. e-Pub 2013. PMID: 24041869.

Manuals, Teaching Aids, Other Teaching Publications

1. Stolar K, Gulbis A, McConn K, Ariza-Heredia E.. Vaccination after Stem Cell Transplant. Patients Questions and Answers, 2015.

Abstracts

1. Khawaja F, Sadaka C, Angelidakis G, Trager S, Spallone A, Ariza-Heredia EJ, Shpall E, Chemaly RF. The Use of Cytomegalovirus (CMV) T Cell Immunity Panel to Assess the Risk of CMV Infection in Recipients of Cellular Therapy with Low Level CMV Viremia. International Immunocompromised Host Society ICHS (22nd Biennial Symposium), Basel, Switzerland, 2022.
2. Spallone A, Khawaja F, Ariza-Heredia EJ, Papanicolaou G, Boeckh M, Dadwal S, Abidi M, Camargo JF, El Boghdadly Z, Shahid Z, Chemaly RF. Transplant Providers’ Perceptions of COVID-19 Vaccination in the Wake of a Global Pandemic. The 2022 Tandem Meetings, Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, Salt Lake City, Utah, 2022.
3. Spallone A, Khawaja F, Ariza-Heredia EJ, Papanicolaou G, Boeckh M, Dadwal S, Abidi M, Camargo JF, El Boghdadly Z, Shahid Z, Chemaly RF. Transplant Providers’ Perceptions of COVID-19 Vaccination in the Wake of a Global Pandemic. The 32th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Lisbon, Portugal, 2022.
4. Angelidakis G, Chemaly RF, Kebriaei P, Ajami NJ, Bhatti M, Shpall E, Hosing C, Jain P, Mahadeo KM, Khawaja F, Wargo J, Jenq R Ariza-Heredia EJ. Evaluation of Retained Immunity for Tetanus-Diphtheria and Pneumococcal Vaccines in Recipients of Cellular Therapies. The 2021 ID Week, 2021.
5. Spallone A, Srinivasan K, Sassine J, Shigle TL, Handy VW, Ramdial J, Khawaja F, Ariza-Heredia EJ, Chemaly RF. The Impact of Clinically Significant CMV Infections on Other Viral Infections in the Era of Letermovir Primary Prophylaxis. The 2021 ID Week, 2021.
6. Sassine J, Khawaja F, Shank BR, Lovell A, Lee J, DiPippo A, Rausch C, Spallone A, Ariza-Heredia EJ, Chemaly RF. Clinically Significant CMV Infections in Patients with Lymphoma or Multiple Myeloma. The 2021 ID Week, 2021.
7. Khawaja F, Sadaka C, Trager S, Fernandes K Ariza-Heredia EJ, Spallone A, Altrich M, Cheamly RF. The Use of a Commercially Available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia. The 2021 ID Week, 2021.
8. Khawaja F, Mullane K, Ariza-Heredia EJ, El Haddad L, Tang Y, Raval AD, Chemaly RF. Healthcare Cost and Length of Stay for Cytomegalovirus (CMV) Infection-Related Hospitalizations in Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients: A Multicenter Analysis. The 2020 ID Week, 2020.
9. Sassine J, Khawaja F, Handy V, Shigle TL, Foolad F, Aitken S, Ariza-Heredia EJ, Chemaly RF. Refractory and Resistant CMV Infections in Hematopoietic Cell Transplant Recipients in the Letermovir Primary Prophylaxis Era. The 2020 ID Week, 2020.
10. De la Rosa Martinez D, Vilar-Compte D, Batista M, Khawaja F, Ariza-Heredia EJ, Chemaly R. Respiratory Viral Infections in Patients with Lymphoma and Multiple Myeloma: Risk Factors Associated with Progression to Lower Respiratory Tract Infection and Mortality. The 2019 ID Week, Washington, District of Columbia, 2019.
11. Strati P, Adkins S, Nastoupil L, Westin J, Hagemeister F, Fowler N, Lee H, Fayad L, Samaniego S, Varma A, Arafat S, Johncy S, Kebriaei P, Mulanovich V, Ariza-Heredia E, Neelapu S. Hematopoietic Recovery and Immune Reconstitution after Axi-cell CAR T-Cell Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma. The 2019 ASCO Annual Meeting, Chicago, Illinois, 2019.
12. Ariza-Heredia EJ, Sacca L, Batista M, El Haddad L, Khawaja F, Viola GM, Hachem J. Outcomes of Influenza Infection in Vaccinated and Non-Vaccinated Patients with Cancer. The 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands, 2019.
13. Viola GM, Rolston KV, Butler C, Selber J, Reece G, Clemens M, Villa M, Ariza-Heredia EJ, Raad I, Baumann D. Are Current Perioperative Antimicrobial Regimens Adequate for the Prevention of Breast Implant-Based Reconstructive Surgeries?. The 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands, 2019.
14. Aldoss I, Baden L, Ariza-Heredia E, La Rosa C, Longmate J, Slape C, Duarte L, Dagis A, Farol L, Nademanee A, Al Malki M, Issa N, Pandit A, Haddad Arbona E, Zaia J, Forman S, Nakamura R, Diamond D. Multi-Antigen Vaccine (TRIPLEX) Based on Attenuated Poxvirus Prevents Cytomegalovirus Viremia in a Multi-Center Placebo Controlled, Double Blinded, Randomized Phase 2 Clinical Trials in Allogeneic HCT Recipients. The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), Frankfurt, Germany, 2019.
15. Batista M, Artau A, Aitken S, Khawaja F, El Chaer F, El Haddad L, Mulanovich V, Ariza-Heredia E, Chemaly R. Clinical Validation of the Definitions of Resistant and Refractory Cytomegalovirus (CMV) Infection and Disease in Hematopoietic Cell Transplant (HCT) Recipients. The 2019 Transplantation & Cellular Therapy Meetings, Houston, Texas, 2019.
16. Sacca L, Chemaly R, Batista M, Jiang Y, El Haddad L, Ariza-Heredia E. Impact of Influenza Vaccination on Outcomes of Influenza Infections in Immunocompromised Patients. The 2019 Transplantation & Cellular Therapy Meetings, Houston, Texas, 2019.
17. Kulkarni P, Kmeid J, Batista M, Ariza-Heredia E, Graviss E, Mulanovich V, Chemaly RF.. Comparison of Interferon-gamma Release Assays (IGRAs) for Diagnosis of Latent or Active Tuberculosis in Cancer Patients. The 2018 ID Week, San Francisco, California, 2018.
18. Artau A, Aitken S, Batista M, El Chare F, Prayag A, El Haddad M, Mulanovich V, Ariza-Heredia E, Chemaly R.. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant. The 2018 ID Week, San Francisco, California, 2018.
19. Khawaja F, Lynn T, Ghantoji S, Batista M, Ariza-Heredia E, Chemaly RF.. The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopoietic Cell Transplant (HCT) Recipients. The 2018 ID Week, San Francisco, California, 2018.
20. Foolad F, Aitken S, Shigle T, Prayag A, Ghanthoji S, Shah D, Ariza-Heredia E, Chemaly R. Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant Recipients. The 2017 ID Week, San Diego, California, 2017.
21. Ariza-Heredia E, Hwang JP, Viola GM, Chemaly RF, Jiang Y, Ramondetta L, Guo M, Ahmed S.. Time to Re-Evaluate Recommendations for Prevention of Human Papillomavirus (HPV) Infections after Stem Cell Transplantation (HSCT). The 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, 2017.
22. Ariza-Heredia EJ, Shah DP, Winston DJ, Rowley SD, Mullane KM, Chandrasekar P, Hari P, Avery R, Peggs KS, Kumar D, Nath R, Ljungman PT, Mossad S, Dadwal SS, Cruikshank W, Chemaly RF. A Prospective Observational Study to Evaluate a Cytomegalovirus (CMV) Specific Enzyme-Linked Immunospot (Elispot) Assay in Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients: The REACT Study. The 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, 2017.
23. Ariza-Heredia E, Hwang JP, Ming Guo, Chemaly RF, Ahmed S.. Risk Factors for HPV Positivity in Patients who received Allogeneic Stem Cell Transplant. The 43rd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT 2017), Marseille, France, 2017.
24. Ariza-Heredia E, Shah DP, El Chaer F, Chemaly RF.. The Ability of CMV-Specific Elispot Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients. The 2017 Bone Marrow Transplant (BMT) Tandem Meeting, Orlando, Florida, 2017.
25. Ariza-Heredia EJ, Shah DP, Winston DJ, Rowley SD, Mullane KM, Chandrasekar P, Hari P, Avery R, Peggs KS, Kumar D, Nath R, Ljungman PT, Mossad S, Dadwal SS, Cruikshank W, Chemaly RF. The Impact of Pre- and Week 4 Post-Transplant CMV-Specific Elispot Assay on CMV Reactivation and Survival in CMV-Seropositive Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients. The 2017 Bone Marrow Transplant (BMT) Tandem Meeting, Orlando, Florida, 2017.
26. Ariza-Heredia EJ, Shah DP, Winston DJ, Rowley SD, Mullane KM, Chandrasekar P, Hari P, Avery R, Peggs KS, Kumar D, Nath R, Ljungman PT, Mossad S, Dadwal SS, Cruikshank W, Chemaly RF. A Prospective Observational Study to Evaluate a Cytomegalovirus (CMV)-Specific Enzyme-Linked Immunospot (Elispot) Assay in Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients: The REACT Study. The 2017 Bone Marrow Transplant (BMT) Tandem Meeting, Orlando, Florida, 2017.
27. Ariza-Heredia E, Shah D, El Chaer F, Mullane K, Rowley S, Chandrasekar P, Winston D, Hari P, Gillis H, Nath R, Kumar D, Mossad S, Ljungman P, Chemaly R.. A Prospective Observational Study to Evaluate a Cytomegalovirus (CMV) specific T-SPOT® Assay in Hematopoietic Stem Cell Transplant Recipients: The REACT Study Interim Data Review. The 2016 ID Week, New Orleans, Louisiana, 2016.
28. Shah D, Ariza-Heredia E, El Chaer F, El Haddad L, El-Haddad E, Prayag P, Nesher L, Rezvani K, Shpall E, Chemaly R. The ability of CMV–specific ELISPOT assay to predict outcome of low level CMV reactivation in hematopoietic cell transplant recipients. The 2016 ID Week, New Orleans, Louisiana, 2016.
29. Taremi M, Shah D,El-Haddad D, El Chaer F, El Haddad L, Prayag A, Rondon G, Hosing C, Ariza-Heredia E, Chemaly R.. Rhinovirus Infections (RhVI) in 233 Hematopoietic Cell Transplant (HCT) Recipients: A Single Center Experience. The 2016 ID Week, New Orleans, Louisiana, 2016.
30. Vakil E, Faiz S, Shah DP, Kmeid J, El Chaer F, Bashoura L, Ariza-Heredia E, Chemaly RF.. Evaluation of Bronchoscopy and Radiographic Imaging in Respiratory Syncytial Virus Infection in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients. The American Thoracic Society Conference, San Francisco, California, 2016.
31. Larson AJ, MacKenney K, Jimenez C, Ariza-Heredia EJ, Knox A, Murphy V, Balachandran D, Ost DE, Immanivong N, Shannon VR, Grosu HB, Eapen GA, Faiz SA, Bashoura L.. Pneumococcal Vaccination in a Cancer Center. The American Thoracic Society Conference, San Francisco, California, 2016.
32. Ariza-Heredia EJ; Chemaly RF, Jiang Y, Mulanovich VE. High Morbidity of Acyclovir Resistant Herpes Simplex Virus Infections among Allogeneic Stem Cell Transplant Recipients . The University of Texas MD Anderson Cancer Center, Division of Internal Medicine, 2016 Research Retreat, Houston, Texas, 2016.
33. Ariza-Heredia EJ, Viola GM, Blue Schaneville K, Gulbis A, Chemaly R, Rolston K, Stolar K. Evaluation of Long-Term Immunity to Varicella, Measles, Mumps, Rubella in Hematopoietic Stem Cell Transplant Survivors. The 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands, 2016.
34. Mahale P, Sturgis EM, Tweardy DJ, Ariza-Heredia EJ, Torres HA. Association between Hepatitis C Virus and Head and Neck Cancers. The University of Texas MD Anderson Cancer Center, Division of Internal Medicine, 2016 Research Retreat, Houston, Texas, 2016.
35. Shah DP, Ghantoji SS, Azzi J, Avadhanula V, Kmeid J, El Chaer F, Ariza-Heredia EJ, Shah N, Mulanovich VE, Hosing C, Piedra P, Chemaly RF. An Open Label, Block Randomized, Ribavirin Efficacy Trial for Management of RSV Infections in Hematopoietic Cell Transplant Recipients: Clinical and Economic Implications. The 2016 Bone Marrow Transplant (BMT) Tandem Meeting, Honolulu, Hawaii, 2016.
36. Ariza-Heredia EJ, Chemaly RF, Jiang Y, Mulanovich VE. Acyclovir Resistant Herpes Simplex Virus in Stem Cell Transplant Recipients. The 2016 Bone Marrow Transplant (BMT) Tandem Meeting, Honolulu, Hawaii, 2016.
37. El Chaer F, Shah DP, Kmeid J, Ariza-Heredia EJ, Hosing C, Chemaly RF. Human Metapneumovirus Infections in 83 Hematopoetic Cell Tranplant Recipients. The 2016 Bone Marrow Transplant (BMT) Tandem Meeting, Honolulu, Hawaii, 2016.
38. Kmeid J, Shah DP, El Chaer F, Ariza-Heredia EJ, Graviss E, Mulanovich VE, Chemaly RF. The Utility of Interferon-Gamma Release Assays for the Diagnosis of Mycobacterium Tuberculosis in Hematopoietic Cell Transplant Recipients. The 2016 Bone Marrow Transplant (BMT) Tandem Meeting, Honolulu, Hawaii, 2016.
39. Viola GM, Ariza-Heredia EJ, Mulanovich VE. Disseminated Strongyloidiasis and Hematopoietic Stem Cell Transplantation. The 2016 Bone Marrow Transplant (BMT) Tandem Meeting, Honolulu, Hawaii, 2016.
40. Kmeid J, Shah DP, El Chaer F, Ariza-Heredia EJ, Graviss E, Mulanovich V, Chemaly RF. The Utility of Interferon-Gamma Release Assays (IGRAs) for the Diagnosis of Mycobacterium Tuberculosis (Mtb) in Cancer Patients. The 2015 ID Week, San Diego, California, 2015.
41. El Chaer F, Shah D, Kmeid J, Ariza-Heredia EJ, Hosing C, Chemaly RF. Human Metapneumovirus (hMPV) infections in 135 Cancer Patients. The 2015 ID Week, San Diego, California, 2015.
42. Kmeid J, Vanichanan J, Shah D, El Chaer F, Azzi J, Ariza-Heredia EJ, Mulanovich V, Chemaly RF. Clinical Outcomes Following Influenza Including 2014/H3N2 Infection in Hematopoietic Cell Transplant (HCT) Recipients. The 2015 ID Week, San Diego, California, 2015.
43. Shah DP, Nesher L, Ariza E, Azzi JM, Siddiqui H, Ghantoji SS, Marsh L, El Chaer F, Makedonas G, Rezvani K, Shpall E, Chemaly RF. Dynamics of CMV-specific T cell Recovery in Allogeneic Hematopoietic Cell Transplant Recipients: Implications for Clinical Outcomes. The 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, 2015.
44. Shah DP, Ghantoji S, Azzi JM, Avadhanula V, El Chaer F, Ariza E, Mulanovich V, Piedra P, Chemaly RF. Cost-effectiveness of Immunodeficiency Scoring Index (ISI-RSV) and Oral Ribavirin for Management of Respiratory Syncytial Virus (RSV) Infections in Hematopoietic Cell Transplant (HCT) Recipients. The 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, 2015.
45. Shah DP, Avadhanula V, Piedra P, Ghantoji S, Aziz J, Ariza-Heredia E, Chemaly R. Viral Genomic Load Kinetics in Hematopoietic Cell Transplant (HCT) Recipients with Respiratory Syncytial Virus (RSV) Infections: A Single Center Cluster-Randomized, Ribavarin Efficacy Trial. The University of Texas MD Anderson Cancer Center, Division of Internal Medicine, 2015 Research Retreat, Houston, Texas, 2015.
46. Nesher L, Ariza-Heredia E, Shah D, Azzi J, Ghantoji S, Michadilis L, Rezvani K, Shpall E, Chemaly R. The Impact of IL-28b Polymorphism in Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients on Interferon (INF Gamma) Production and CMV Reactivation. The 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Washington, DC, 2014.
47. Nesher L, Ariza-Heredia E, Shah D, Azzi J, Ghantoji S, Michadilis L, Rezvani K, Shpall E, Chemaly R. Immune Monitoring with the T-SPOT CMV Assay of Allogeneic Hematopoietic Stem Cell Transplant (allo-HCT) Recipients: A Proof of Concept in the Clinical Setting. The 54th Intersciensce Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Washington, DC, 2014.
48. Shah D, Avadhanula V, Piedra P, Ghantoji S, Azzi J, Ariza-Heredia E, Nesher L, Marsh L, Delano E, Chemaly R. Viral Genomic Load (VGL) Kinetics in Hematopoietic Stem Cell Transplant (HCT) Recipients with RSV Infections. The 54th Intersciensce Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Washington, DC, 2014.
49. Azzi J, Bashoura L, Shah D, Alousi A, Ghantoji S, Nesher L,Rondon G, Ariza-Heredia E, Chemaly R. The Long-Term Impact of Respiratory Viral Infections (RVI) on Pulmonary Function in Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients. The 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Washington, DC, 2014.
50. Nesher L, Chemaly RF, Rezvani K, Shpall E, Shah D, Ariza-Heredia E. Immune Monitoring of Allogeneic Hematopoietic Stem Cell Transplantat (allo-HSCT) Recipients at Risk for Cytomegalovirus (CMV) Reactivation: A Prospective Observational Study. The University of Texas MD Anderson Cancer Center, Division of Internal Medicine, 2014 Research Retreat, Houston, Texas, 2014.
51. Torres HA, Ralllapalli V, Saxena A, Granwehr B, Viola G, Ariza-Heredia E, Adachi J, Chemaly R, Marfatia R, Jiang Y, Mahale P, Kyvernitakis A, Fanale M, Mulanovich V.. Efficacy and Safety of Antiretrovirals in HIV-infected Patients with Cancer. The University of Texas MD Anderson Cancer Center, Division of Internal Medicine, 2014 Research Retreat, Houston, Texas, 2014.
52. Viola GM, Adachi JA, Ariza-Heredia E, Yang W, Villa MT, Butler CE, Kronowitz S, Clemens MW, Selber JC, Baumann DP. Breast Tissue Expander-Related Infections: A Standardized Multidisciplinary Approach to Salvaging the Implant. The 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Barcelona, Spain, 2014.
53. Ariza-Heredia EJ, Gulbis A, Kebriae P, Stolar K, McConn K, Mulanovich V, Viola G, Chemaly RF.. Compliance with Post-Haematopoietic Stem Cell Transplantation Vaccination Consensus Guidelines. The 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Barcelona, Spain, 2014.
54. Doan V, Yeh J, Gulbis A, Ariza-Heredia E, Ahmed S.. Levofloxacin versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation. The 10th Annual Hematology-Oncology Pharmacy Association (HOPA) Annual Conference, New Orleans, Lousiana, 2014.
55. Nesher L, Sha D, Ariza-Heredia D, Rolston K, Chemaly R.. Pseudomonas aeruginosa Predicts Infection in Recipients of Allogeneic Stem Cell Transplantation. The 2013 ID Week, San Francisco, California, 2013.
56. Vanichanan J, Nieto Y, Mulanovich V, Ariza-Heredia E, Roldon G, Shah D, Chemaly R.. Central Nervous System Complications After Hematopoietic Stem Cell Transplantation. The 2013 ID Week, San Francisco, California, 2013.
57. Ariza-Heredia EJ, Gulbis A, Stolar K, Kebriae P, McConn K, Champlin R, Mulanovich V, Chemaly R. Vaccination Guidelines after Stem Cell Transplantation: Practitioner's Knowledge and Attitudes, and the Gap between Guidelines and Clinical Practice. The 2013 ID Week, San Francisco, California, 2013.
58. Torres HA, Rallapalli V, Saxena A, Granwehr BP, Viola G, Ariza-Heredia E, Chemaly RF, Jiang Y, Marfatia R, Shelburne S, Mulanovich V. Efficacy and Safety of Antiretrovirals in HIV-Infected Patients with Cancer. The 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Denver, Colorado, 2013.
59. Shah D, Alousi A, Bashoura L, Ghantoji S, Rondon G, Mulanovich V, Ariza Heredia E, Chemaly R.. Validating an Immunodeficiency Scoring Index (ISI) to Predict Pneumonia and Mortality in Allogeneic Stem Cell Transplant (allo-HCT) recipients with RSV, Influenza, and Parainfluenza Virus Infections. Third Infections in Cancer Symposium, Houston, Texas, 2013.
60. Vanichanan J, Vilar-Compte D, Shah D, Volkow P, Cornejo-Juarez P, Perez-Jimenez C, Saad M, Mulanovich V, Ariza-Heredia E, Chemaly R. A Multicenter Study of Pandemic H1N1 Influenza (pH1N1) Infections in Patients with Hematologic Malignancies (HM) and Hematopoietic Cell Transplant (HCT) Recipients from 3 Countries. Third Infections in Cancer Symposium, Houston, Texas, 2013.
61. Shah D, Alousi A, Bashoura L, Shah P, Mahajan S, Mulanovich V, Ariza-Heredia E, Chemaly R.. Bronchiolitis Obliterans following Respiratory Viral Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients. The 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). San Francisco, California, 2012.
62. Mahajan SN, Ghantoji SS, Shah DJ, Mulanovich VE, Ariza-Heredia EJ, Chemaly RF. Impact of RSV Infection in Patients with Lymphoma or Multiple Myeloma (MM): A Single Center Study. The 52nd Intersciensce Conference on Antimicrobial Agents and Chemotherapy (ICAAC). San Francisco, California, 2012.
63. Ariza Heredia E, Kazimirko E, Lesnick T, Kremers W, Cosio F, Razonable R. Trimethoprim-Sulfamethoxazole (TMP-SMZ) Prophylaxis for Pneumocystis jirovecii (PCP) Reduces the Risk of Urinary Tract Infection and its Recurrence in Kidney Transplant Recipients. The 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, 2011.
64. Ariza Heredia EJ, Fishman J, Cleary T, Smith L, Razonable RR, Abbo L. Clinical and Radiological Findings of Respiratory Syncytial Virus in Solid Organ Transplant Recipients. The American Transplant Congress, Philadelphia, Pennsylvania, 2011.
65. Ariza Heredia E, Kremers W, Lesnick T, Cosio F, Razonable RR. Urinary Tract Infection in Solitary Kidney Transplant Recipients: An Institutional Cohort Study of Risk Factors and Allograft Outcomes. The American Transplant Congress, Philadelphia, Pennsylvania, 2011.
66. Ariza Heredia EJ, Dezfulian C, Morris MM, Munoz-Price S. Retrospective Review of Gram-Negative Bacteremia in Solid Organ Transplant Population. The 48th Annual Meeting of the Infectious Diseases Society of America (IDSA), Vancouver, Canada, 2010.
67. Munoz-Price S, Dezfulian C, Ariza-Heredia E, Adams S, Olivier M, Francois L, Socarras M, Coro G, Adedokun A, Pappas T, Tamayo M. Brief UV Powder Surveillance and Reporting Results in Sustained Improvements in ICU Environmental Cleaning. The 48th Annual Meeting of the Infectious Diseases Society of America (IDSA), Vancouver, Canada, 2010.
68. Munoz-Price S, Adams S, Ariza-Heredia E. Improvement in Operating Room Environmental Cleaning Using UV Powder Surveillances. The 48th Annual Meeting of the Infectious Diseases Society of America (IDSA), Vancouver, Canada, 2010.
69. Ariza-Heredia EJ, Garisto J, Carrillo R. Correlation of Fever and Elevated Leukocyte Count with Chest CT Findings of Septic Pulmonary Emboli in Cardiac Device Related Infections. The 47th Annual Meeting of the Infectious Diseases Society of America (IDSA), Philadelphia, Pennsylvania, 2009.

Book Chapters

1. Ariza-Heredia EJ, El Chaer F, Chemaly RF.. Antiviral Treatment and Prophylaxis in Immunocompromised Host. In: Management of Infections in the Immunocompromised Host. Springer, 317-337, 2018.
2. Ariza-Heredia EJ, Chemaly RF. Influenza and Parainfluenza Infections after Hematopoietic Stem Cell and Solid Organ Transplantation. In: Transplant Infections. 4th. Springer, 2016.
3. Baracco G, Ariza-Heredia E. Neisseria meningitidis. In: Infection Control and Epidemiology. 3rd, 75:1-5, 2009.
4. Ariza-Heredia EJ, Viola GM. Antimicrobial Management of Neutropenic Fever in Hematopoietic Stem Cell Transplant Recipients. In: The AST Handbook of Transplant Infections. Wiley.